SCHEMBL3141883

SCHEMBL3141883

Cc1nc(C(N)=O)sc1-c1ccc(S(C)(=O)=O)c(-n2ccnc2)c1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 11/20 0.41
PIK3CA P42336 11/20 0.41
PIK3CG P48736 11/20 0.41
PIK3CB P42338 9/20 0.41
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
CLK1 P49759 1/20 0.33
CLK2 P49760 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPK1 P28482 1/20 0.33
ADH5 P11766 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48644 0.85 PIK3CD (0.39) PIK3CDPIK3CAPIK3CGPIK3CBMAOA
SCHEMBL48534 0.82 PIK3CG (0.64) PIK3CDPIK3CAPIK3CGPIK3CBPI4KB
Sulfuric Acid SCHEMBL17203250 0.81 PIK3CG (0.62) PIK3CDPIK3CAPIK3CGPIK3CBPI4KB
Sulfuric Acid SCHEMBL17203266 0.80 PIK3CG (0.61) PIK3CDPIK3CAPIK3CGPIK3CBPI4KB
Sulfuric Acid SCHEMBL17203127 0.80 PIK3CG (0.61) PIK3CDPIK3CAPIK3CGPIK3CBPI4KB
SCHEMBL48826 0.80 PIK3CD (0.51) PIK3CDPIK3CAPIK3CGPIK3CBCLK1
Sulfuric Acid SCHEMBL17202949 0.80 PIK3CG (0.61) PIK3CDPIK3CAPIK3CGPIK3CBPI4KB
SCHEMBL48709 0.80 PIK3CD (0.51) PIK3CDPIK3CAPIK3CGPIK3CBCLK1
Sulfuric Acid SCHEMBL17202951 0.80 PIK3CG (0.61) PIK3CDPIK3CAPIK3CGPIK3CBPI4KB
SCHEMBL49251 0.79 PIK3CD (0.52) PIK3CDPIK3CAPIK3CGPIK3CBCLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2311818-B1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug NOVARTIS AG (CH) 2013-01-16 EP disclosed
EP-1555267-B1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES OTSUKA PHARMA CO LTD (JP) 2013-01-16 EP disclosed
US-20100093690-A1 5-PHENYLTHIAZOLE DERIVATIVES AND USE AS PI3 KINASE INHIBITORS BRUCE IAN 2010-04-15 US disclosed
US-7687637-B2 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors NOVARTIS AG (CH) 2010-03-30 US disclosed
US-20050119320-A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors NOVARTIS AG (CH) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093690-A1 5-PHENYLTHIAZOLE DERIVATIVES AND USE AS PI3 KINASE INHIBITORS PIK3CA, PIK3R5, PIP5K1B PIK3CD 4/4885PIK3CA 1/4885PIK3CG 8/4885
US-20050119320-A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors PIK3CA, PIK3R5, PIP5K1B PIK3CD 4/4885PIK3CA 1/4885PIK3CG 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.